title: [Melatoninergic antidepressant valdoxan].
abstract: Data on the pharmacological properties, mechanism of action, and clinical advantages of the new antidepressant drug valdoxan capable of selectively stimulating melatonin receptors are presented. The drug effect is compared to the action of epiphyseal hormone melatonin and traditional antidepressants.
authors: É B
authors: ÉB
authors: Arushanian
mesh_terms: D000081:Acetamides / Q000494:pharmacology* / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002940:Circadian Rhythm / Q000187:drug effects; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008550:Melatonin / Q000494:pharmacology; D010870:Pineal Gland / Q000378:metabolism; D044094:Receptors, Melatonin / Q000819:agonists* / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D000928:Antidepressive Agents; D008550:Melatonin; D044094:Receptors, Melatonin; D011985:Receptors, Serotonin; D012701:Serotonin; D012702:Serotonin Antagonists; C084711:agomelatine; D009281:Naphthalenes